Biomaster
Yokohama-shi
About Biomaster
Biomaster is a developer of regenerative medicines. The company's regenerative medicines include adipose derived stem cell, enabling the medical industry to increases the soft tissue of the body for fighting facial degenerative diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Last round: Corporate Round (Nov 2009)
- Website: biomaster.jp
- Phone: 045-222-3363
Industries & Categories
Health Care
Canonical: https://fsome.com/organization/biomaster-3410957 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.